# AstraZeneca timeline entity: /record/astrazeneca.md id: ent_astrazeneca AstraZeneca's timeline holds 65 claims from 1995 to 2025: 56 money & deals, 9 other. 7 are undated. The latest took effect on December 31, 2025. Kinds: People 0 (/timelines/astrazeneca.md?kind=people) · Money & deals 56 (/timelines/astrazeneca.md?kind=money) · Products 0 (/timelines/astrazeneca.md?kind=products) · Models 0 (/timelines/astrazeneca.md?kind=models) · Other 9 (/timelines/astrazeneca.md?kind=other) Format: date | kind | predicate | value | status | claim. ## 1995 - 1995-03-13 to 1999-02-05 | other | registrant_name | ZENECA GROUP PLC | superseded | [clm_5C035E7A6F9A](/claim/clm_5C035E7A6F9A.md) ## 1999 - 1999-02-05 | other | registrant_name | ASTRAZENECA PLC | valid | [clm_CC0A4381A0A0](/claim/clm_CC0A4381A0A0.md) ## 2014 - 2014-12-31 to 2015-12-31 | money | total_equity | 19,646,000,000 United States dollar | superseded | [clm_1A634ECF5C3D](/claim/clm_1A634ECF5C3D.md) ## 2015 - 2015-12-31 to 2016-12-31 | money | net_income | 2,826,000,000 United States dollar | superseded | [clm_DEF1603E885B](/claim/clm_DEF1603E885B.md) - 2015-12-31 to 2016-12-31 | money | operating_income | 4,114,000,000 United States dollar | superseded | [clm_9CE71799FE73](/claim/clm_9CE71799FE73.md) - 2015-12-31 to 2016-12-31 | money | revenue | 24,708,000,000 United States dollar | superseded | [clm_E7354F8FC4AB](/claim/clm_E7354F8FC4AB.md) - 2015-12-31 to 2016-12-31 | money | total_assets | 60,056,000,000 United States dollar | superseded | [clm_39CC74EC0018](/claim/clm_39CC74EC0018.md) - 2015-12-31 to 2016-12-31 | money | total_equity | 18,509,000,000 United States dollar | superseded | [clm_4F3F4354CA13](/claim/clm_4F3F4354CA13.md) ## 2016 - 2016-12-31 to 2017-12-31 | money | net_income | 3,406,000,000 United States dollar | superseded | [clm_194B34501880](/claim/clm_194B34501880.md) - 2016-12-31 to 2017-12-31 | money | operating_income | 4,902,000,000 United States dollar | superseded | [clm_654CC8AE2812](/claim/clm_654CC8AE2812.md) - 2016-12-31 to 2017-12-31 | money | revenue | 23,002,000,000 United States dollar | superseded | [clm_904F793B66AA](/claim/clm_904F793B66AA.md) - 2016-12-31 to 2017-12-31 | money | total_assets | 62,526,000,000 United States dollar | superseded | [clm_4B2074B77E0B](/claim/clm_4B2074B77E0B.md) - 2016-12-31 to 2017-12-31 | money | total_equity | 16,669,000,000 United States dollar | superseded | [clm_B272D51F85BC](/claim/clm_B272D51F85BC.md) ## 2017 - 2017-12-31 to 2018-12-31 | money | net_income | 2,868,000,000 United States dollar | superseded | [clm_7BDCCD2AEF61](/claim/clm_7BDCCD2AEF61.md) - 2017-12-31 to 2018-12-31 | money | operating_income | 3,677,000,000 United States dollar | superseded | [clm_77DE63410430](/claim/clm_77DE63410430.md) - 2017-12-31 to 2018-12-31 | money | revenue | 22,465,000,000 United States dollar | superseded | [clm_B25F0718A827](/claim/clm_B25F0718A827.md) - 2017-12-31 to 2018-12-31 | money | total_assets | 63,354,000,000 United States dollar | superseded | [clm_10CF439A8D3D](/claim/clm_10CF439A8D3D.md) - 2017-12-31 to 2018-12-31 | money | total_equity | 16,642,000,000 United States dollar | superseded | [clm_6A3694B18261](/claim/clm_6A3694B18261.md) ## 2018 - 2018-12-31 to 2019-12-31 | money | net_income | 2,050,000,000 United States dollar | superseded | [clm_80CF1A157103](/claim/clm_80CF1A157103.md) - 2018-12-31 to 2019-12-31 | money | operating_income | 3,387,000,000 United States dollar | superseded | [clm_0928C69F436C](/claim/clm_0928C69F436C.md) - 2018-12-31 to 2019-12-31 | money | revenue | 22,090,000,000 United States dollar | superseded | [clm_790001197E10](/claim/clm_790001197E10.md) - 2018-12-31 to 2019-12-31 | money | total_assets | 60,651,000,000 United States dollar | superseded | [clm_39BC161464CE](/claim/clm_39BC161464CE.md) - 2018-12-31 to 2019-12-31 | money | total_equity | 14,044,000,000 United States dollar | superseded | [clm_4F65B3C1FC28](/claim/clm_4F65B3C1FC28.md) ## 2019 - 2019-12-31 to 2020-12-31 | money | net_income | 1,227,000,000 United States dollar | superseded | [clm_529E4815C0D2](/claim/clm_529E4815C0D2.md) - 2019-12-31 to 2020-12-31 | money | operating_income | 2,924,000,000 United States dollar | superseded | [clm_CA91157E8FEC](/claim/clm_CA91157E8FEC.md) - 2019-12-31 to 2020-12-31 | money | revenue | 24,384,000,000 United States dollar | superseded | [clm_08D5EE5A62C8](/claim/clm_08D5EE5A62C8.md) - 2019-12-31 to 2020-12-31 | money | total_assets | 61,377,000,000 United States dollar | superseded | [clm_010DB2BB1408](/claim/clm_010DB2BB1408.md) - 2019-12-31 to 2020-12-31 | money | total_equity | 14,596,000,000 United States dollar | superseded | [clm_7E8748E6B574](/claim/clm_7E8748E6B574.md) ## 2020 - 2020-12-31 to 2021-12-31 | money | net_income | 3,144,000,000 United States dollar | superseded | [clm_B737A429D7E9](/claim/clm_B737A429D7E9.md) - 2020-12-31 to 2021-12-31 | money | operating_income | 5,162,000,000 United States dollar | superseded | [clm_D4ADC56D2F76](/claim/clm_D4ADC56D2F76.md) - 2020-12-31 to 2021-12-31 | money | revenue | 26,617,000,000 United States dollar | superseded | [clm_85B6D134E13C](/claim/clm_85B6D134E13C.md) - 2020-12-31 to 2021-12-31 | money | total_assets | 66,729,000,000 United States dollar | superseded | [clm_BFC9DC65FD19](/claim/clm_BFC9DC65FD19.md) - 2020-12-31 to 2021-12-31 | money | total_equity | 15,638,000,000 United States dollar | superseded | [clm_F30C48EE7B4A](/claim/clm_F30C48EE7B4A.md) ## 2021 - 2021-12-31 to 2022-12-31 | money | net_income | 115,000,000 United States dollar | superseded | [clm_F01EE117485C](/claim/clm_F01EE117485C.md) - 2021-12-31 to 2022-12-31 | money | operating_income | 1,056,000,000 United States dollar | superseded | [clm_10DEC07C1593](/claim/clm_10DEC07C1593.md) - 2021-12-31 to 2022-12-31 | money | revenue | 37,417,000,000 United States dollar | superseded | [clm_47272A7D1B25](/claim/clm_47272A7D1B25.md) - 2021-12-31 to 2022-12-31 | money | total_assets | 105,363,000,000 United States dollar | superseded | [clm_BAB2B4420BCE](/claim/clm_BAB2B4420BCE.md) - 2021-12-31 to 2022-12-31 | money | total_equity | 39,287,000,000 United States dollar | superseded | [clm_515C40C5227C](/claim/clm_515C40C5227C.md) ## 2022 - 2022-12-31 to 2023-12-31 | money | net_income | 3,293,000,000 United States dollar | superseded | [clm_AE6BE83BCC88](/claim/clm_AE6BE83BCC88.md) - 2022-12-31 to 2023-12-31 | money | operating_income | 3,757,000,000 United States dollar | superseded | [clm_F928384EA602](/claim/clm_F928384EA602.md) - 2022-12-31 to 2023-12-31 | money | revenue | 44,351,000,000 United States dollar | superseded | [clm_31557855C15A](/claim/clm_31557855C15A.md) - 2022-12-31 to 2023-12-31 | money | total_assets | 96,483,000,000 United States dollar | superseded | [clm_A839065669A3](/claim/clm_A839065669A3.md) - 2022-12-31 to 2023-12-31 | money | total_equity | 37,058,000,000 United States dollar | superseded | [clm_CC377A6E41D1](/claim/clm_CC377A6E41D1.md) ## 2023 - 2023-12-31 to 2024-12-31 | money | net_income | 5,961,000,000 United States dollar | superseded | [clm_9F87514064CD](/claim/clm_9F87514064CD.md) - 2023-12-31 to 2024-12-31 | money | operating_income | 8,193,000,000 United States dollar | superseded | [clm_7E98BE75827B](/claim/clm_7E98BE75827B.md) - 2023-12-31 to 2024-12-31 | money | revenue | 45,811,000,000 United States dollar | superseded | [clm_1A1A4ACC29CB](/claim/clm_1A1A4ACC29CB.md) - 2023-12-31 to 2024-12-31 | money | total_assets | 101,119,000,000 United States dollar | superseded | [clm_CD9BD69D497F](/claim/clm_CD9BD69D497F.md) - 2023-12-31 to 2024-12-31 | money | total_equity | 39,166,000,000 United States dollar | superseded | [clm_91657DA81B37](/claim/clm_91657DA81B37.md) ## 2024 - 2024-12-31 to 2025-12-31 | money | net_income | 7,041,000,000 United States dollar | superseded | [clm_DCF412B5DDDA](/claim/clm_DCF412B5DDDA.md) - 2024-12-31 to 2025-12-31 | money | operating_income | 10,003,000,000 United States dollar | superseded | [clm_3994638C1B14](/claim/clm_3994638C1B14.md) - 2024-12-31 to 2025-12-31 | money | revenue | 54,073,000,000 United States dollar | superseded | [clm_5BDDB85A5719](/claim/clm_5BDDB85A5719.md) - 2024-12-31 to 2025-12-31 | money | total_assets | 104,035,000,000 United States dollar | superseded | [clm_F05CE2B1D291](/claim/clm_F05CE2B1D291.md) - 2024-12-31 to 2025-12-31 | money | total_equity | 40,871,000,000 United States dollar | superseded | [clm_702A322E3B09](/claim/clm_702A322E3B09.md) ## 2025 - 2025-12-31 | money | net_income | 10,233,000,000 United States dollar | valid | [clm_7F0BFE9EB1CD](/claim/clm_7F0BFE9EB1CD.md) - 2025-12-31 | money | operating_income | 13,743,000,000 United States dollar | valid | [clm_763AA2791DE9](/claim/clm_763AA2791DE9.md) - 2025-12-31 | money | revenue | 58,739,000,000 United States dollar | valid | [clm_75285D1846DF](/claim/clm_75285D1846DF.md) - 2025-12-31 | money | total_assets | 114,074,000,000 United States dollar | valid | [clm_B12E0C1D9275](/claim/clm_B12E0C1D9275.md) - 2025-12-31 | money | total_equity | 48,719,000,000 United States dollar | valid | [clm_327B10FB292B](/claim/clm_327B10FB292B.md) ## undated - undated | other | cik | 0000901832 | valid | [clm_8820826D4245](/claim/clm_8820826D4245.md) - undated | other | fiscal_year_end | 12-31 | valid | [clm_433F982364C7](/claim/clm_433F982364C7.md) - undated | other | headquarters | Cambridge | valid | [clm_6B4DC8E0E36A](/claim/clm_6B4DC8E0E36A.md) - undated | other | listed_on | NYSE | valid | [clm_43376D897A1F](/claim/clm_43376D897A1F.md) - undated | other | sic_industry | Pharmaceutical Preparations (2834) | valid | [clm_26C4F27CEF84](/claim/clm_26C4F27CEF84.md) - undated | other | state_of_incorporation | X0 | valid | [clm_8352C183E226](/claim/clm_8352C183E226.md) - undated | other | ticker | AZN | valid | [clm_7F36A4D2B72F](/claim/clm_7F36A4D2B72F.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.